EXPRESSION VON NEUROPEPTIDEN

Patent europeic · EP3703716 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3703716
Numer da la dumonda
EP18873220
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
01-11-2018
Publitgà
09-09-2020
Concedì
25-03-2026
La protecziun finescha il pli tard
31-10-2038
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
A61K 35/30 (2015.01)
A61K 48/00 (2006.01)
Prioritad
US 201762580846 P 02.11.2017
Dumonda PCT
PCT/US2018/058808 01.11.2018
Publicaziun PCT
WO2019/090000 09.05.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-03-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 25.03.2026

Partidas

Possessur

California Institute of Technology

1200 East California Boulevard M/C 6-32, Pasadena, CA 91125, US

Inventur

ANDERSON, David, J.

Altadena California 91001, US

ZELIKOWSKY, Moriel

Pasadena California 91125, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.